About AmplexDiagnostics

Since 2002, AmplexDiagnostics GmbH has established a growing network and cooperates with international scientists who bring an extra advance to our research and development. Easy handling, competent training and excellent care are a matter of course for us. Amplex is one of the first suppliers of CE-IVD diagnostics based on isothermal amplification with simultaneous real-time detection. The portable device and lyophilized test reagents ensure maximum user-friendliness. The ready-to-use reactions can be shipped and stored at room temperature. No DNA/RNA extraction is required and testing can be performed directly from the sample. eazyplex® combines robust isothermal amplification with efficient real-time detection! With the new eazyplex® system you can confirm resistance within 15 minutes, screen for multi-resistant bacteria within 20 minutes or perform meningitis diagnostics within 30 minutes. The eazyplex® system, flexible and fast as never before! Our vision is to bring this modern diagnostics to the patient as close as possible.

Facts about AmplexDiagnostics
  • Focus : Manufacturer
  • Employees: 1-10
  • Industry : Diagnostics

Product portfolio of AmplexDiagnostics

Here you will find AmplexDiagnostics GmbH

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures
View topic world

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures